Vaxcyte (PCVX) News Today → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free PCVX Stock Alerts $60.62 -1.81 (-2.90%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineValidea Detailed Fundamental Analysis - PCVXnasdaq.com - April 14 at 10:13 AMVaxcyte (NASDAQ:PCVX) Given "Buy" Rating at Needham & Company LLCamericanbankingnews.com - April 11 at 5:12 AMVaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Saysmsn.com - April 10 at 5:53 PMVaxcyte (NASDAQ:PCVX) Stock Rating Reaffirmed by Needham & Company LLCmarketbeat.com - April 10 at 8:17 AMHead-To-Head Comparison: Vaxcyte (NASDAQ:PCVX) vs. Avalon GloboCare (NASDAQ:ALBT)americanbankingnews.com - April 8 at 1:44 AMVaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 2 at 4:05 PMVaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Analystsmarketbeat.com - March 29 at 4:26 AMGrant Pickering Sells 15,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stockinsidertrades.com - March 28 at 7:55 AMVaxcyte, Inc. (NASDAQ:PCVX) CEO Grant Pickering Sells 15,000 Sharesmarketbeat.com - March 27 at 6:39 PMVanguard Group Inc. Buys 47,872 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - March 25 at 4:32 AMAndrew Guggenhime Sells 8,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stockinsidertrades.com - March 22 at 5:20 AMInsider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Sharesfinance.yahoo.com - March 20 at 9:58 PMVaxcyte, Inc. (NASDAQ:PCVX) CFO Andrew Guggenhime Sells 8,000 Sharesmarketbeat.com - March 20 at 7:36 PM86,431 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Bought by Comerica Bankmarketbeat.com - March 19 at 4:18 AMPCVX Jul 2024 70.000 putca.finance.yahoo.com - March 16 at 1:20 PMPCVX Apr 2024 80.000 putca.finance.yahoo.com - March 16 at 1:20 PMVaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Citigroup Inc.marketbeat.com - March 16 at 5:43 AMPCVX Apr 2024 100.000 callfinance.yahoo.com - March 16 at 1:57 AMWellington Management Group LLP Acquires 167,501 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - March 15 at 6:43 AMVaxcyte, Inc. (NASDAQ:PCVX) Sees Large Decline in Short Interestmarketbeat.com - March 14 at 12:47 PMOracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesdaymsn.com - March 12 at 2:17 PMAdage Capital Partners GP L.L.C. Increases Position in Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - March 10 at 6:37 AMGlenmede Trust Co. NA Acquires Shares of 14,938 Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - March 9 at 6:01 AMVaxcyte, Inc.: Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infantsfinanznachrichten.de - March 4 at 1:30 PMVaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infantsglobenewswire.com - March 4 at 8:30 AMNorthern Trust Corp Boosts Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - March 4 at 5:54 AMSchonfeld Strategic Advisors LLC Buys 23,943 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - March 2 at 8:26 AMBraidwell LP Has $82.57 Million Stake in Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - March 1 at 10:17 AMQ2 2024 Earnings Forecast for Vaxcyte, Inc. (NASDAQ:PCVX) Issued By Leerink Partnrsmarketbeat.com - March 1 at 8:00 AMBuy Rating Affirmed for Vaxcyte Amid Anticipation of Transformative VAX-31 Data Releasemarkets.businessinsider.com - March 1 at 7:26 AMBuy Rating Affirmed for Vaxcyte on Strong Vaccine Candidate Prospects and Upward Financial Projectionsmarkets.businessinsider.com - March 1 at 7:26 AMVaxcyte’s VAX-31 Poised for Market Leadership: Shrader’s Bullish Forecast and Price Target Updatemarkets.businessinsider.com - February 28 at 3:03 PMTD Cowen Remains a Buy on Vaxcyte (PCVX)markets.businessinsider.com - February 28 at 10:02 AMVaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 28 at 10:02 AMNeedham & Company LLC Increases Vaxcyte (NASDAQ:PCVX) Price Target to $95.00marketbeat.com - February 28 at 8:31 AMVaxcyte, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 27 at 10:26 PMAvidity Partners Management LP Has $38.55 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - February 27 at 4:25 PMVaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - February 27 at 4:01 PMVaxcyte Stock (NASDAQ:PCVX), Short Interest Reportbenzinga.com - February 26 at 10:15 AM5 Best Russell 2000 Stocks To Buy According To Hedge Fundsinsidermonkey.com - February 25 at 1:09 PMEAM Investors LLC Trims Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - February 24 at 7:50 AMVaxcyte (NASDAQ:PCVX) Sets New 52-Week High at $77.26marketbeat.com - February 23 at 2:57 PMVaxcyte (PCVX) to Release Earnings on Tuesdaymarketbeat.com - February 20 at 6:29 AMVaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by Citigroup Inc.marketbeat.com - February 20 at 5:59 AMFmr LLC Purchases 20,801 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)marketbeat.com - February 19 at 7:59 AMPCVX Apr 2024 50.000 callfinance.yahoo.com - February 17 at 10:05 PMPCVX Sep 2024 40.000 putfinance.yahoo.com - February 17 at 7:04 AMPCVX Mar 2024 90.000 callfinance.yahoo.com - February 16 at 10:41 PMPCVX Mar 2024 60.000 putfinance.yahoo.com - February 16 at 10:41 PMVaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024finance.yahoo.com - February 15 at 4:38 PM Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story PCVX Media Mentions By Week PCVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCVX News Sentiment▼0.000.49▲Average Medical News Sentiment PCVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCVX Articles This Week▼13▲PCVX Articles Average Week Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Exelixis News Today Revolution Medicines News Today CRISPR Therapeutics News Today Halozyme Therapeutics News Today Krystal Biotech News Today Qiagen News Today Immunovant News Today Repligen News Today Bio-Techne News Today ImmunityBio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCVX) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressThe “Perfect Storm” for GoldGold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.